US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MRBL Enhanced Equity ETF

37.38

+0.24850.67%

Volume:139.00

Turnover:5.20K

Market Cap:1.18B

PE:- -

High:37.45

Open:37.45

Low:37.38

Close:37.13

Loading ...

Overview Company News Filings

Company Profile

Company Name:

MRBL Enhanced Equity ETF

Exchange:

CBOE

Establishment Date:

- -

Employees:

- -

Office Location:

19 East Eagle Road,Havertown,Pennsylvania,United States

Website:

http://www.edgetherapeutics.com

Zip Code:

19083

Phone:

Fax:

216 245 3686

Introduction:

Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EDGE/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EDGE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDGE\",,,,,undefined,":{"symbol":"EDGE","market":"US","secType":"STK","nameCN":"MRBL Enhanced Equity ETF","latestPrice":37.3816,"timestamp":1746734400000,"preClose":37.1331,"halted":0,"volume":139,"delay":0,"floatShares":140000,"shares":31509822,"eps":0,"marketStatus":"Not Yet Opened","change":0.2485,"latestTime":"05-08 16:00:00 EDT","open":37.45,"high":37.45,"low":37.3816,"amount":5204.354,"amplitude":0.001842,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746777600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"CBOE","adjPreClose":37.1331,"sharesOutstanding":140000,"nav":37.2,"aum":5208000,"bidAskSpread":0,"volumeRatio":0.310129},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDGE\",,,,,undefined,":{"symbol":"EDGE","floatShares":140000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.310129,"shares":31509822,"dividePrice":0,"high":37.45,"amplitude":0.001842,"preClose":37.1331,"low":37.3816,"week52Low":31.99,"pbRate":"--","week52High":40.97,"institutionHeld":0,"latestPrice":37.3816,"eps":0,"divideRate":0,"volume":139,"delay":0,"ttmEps":0,"open":37.45,"prevYearClose":40.2,"prevWeekClose":37.3044,"prevMonthClose":36.79,"prevQuarterClose":37.1848,"fiveDayClose":36.975,"twentyDayClose":32.85,"sixtyDayClose":40.335},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1902083742,"address":"19 East Eagle Road,Havertown,Pennsylvania,United States","zipCode":"19083","officePhone":"215 882 9983","officeFax":"216 245 3686"},"stockCompanyDetail":{"websiteUrl":"http://www.edgetherapeutics.com","stockEarnings":[{"period":"1week","weight":0.011},{"period":"1month","weight":0.152},{"period":"3month","weight":-0.0663},{"period":"6month","weight":-0.0701},{"period":"ytd","weight":-0.0701}],"compareEarnings":[{"period":"1week","weight":0.0118},{"period":"1month","weight":0.1381},{"period":"3month","weight":-0.0594},{"period":"6month","weight":-0.0554},{"period":"1year","weight":0.0926},{"period":"ytd","weight":-0.0359}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Edge Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and commercializes hospital-based therapies for acute life-threatening neurological conditions. Its lead product includes EG-1962, a polymer-based microparticle used for the treatment of aneurysmal subarachnoid hemorrhage. The company also develops EG-1964 for the management of chronic subdural hematoma as a prophylactic treatment to prevent recurrent bleeding. The company was founded in 2009 and is headquartered in Berkeley Heights, New Jersey.","exchange":"CBOE","name":"MRBL Enhanced Equity ETF","nameEN":"MRBL Enhanced Equity ETF"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EDGE\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDGE\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDGE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDGE\",market:\"US\",delay:false,,,undefined,":{}}}